内部人交易雷达

美国 · SEC Form 4 · 快照日期: 2026-10-18 · 构建时间: 2026-10-18 · English

← 美国市场 · 覆盖记录

美国 · SEC FORM 4

CapsoVision, Inc

CV · Nasdaq · CIK 0001378325 · Healthcare · Medical Devices

内部人信号

60.1 / 100

1 位买方 · 5 条买入交易行 · $11.0M 买入总额

为什么有这个信号?

买方广度较低
买入规模较强
角色中等
近期性中等
确信度较强
评分构成

每条进度条表示其对当前分数的贡献;权重和公式保持不变。

Cluster+7.0 / 35
买入规模+23.1 / 25
角色+14.0 / 20
近期性+6.1 / 10
确信度+10.0 / 10

哪些因素限制了当前分数?

  • ⚠ Cluster breadth is moderate · 1 insider(s), not 4+
  • ⚠ 角色得分低 · 买入者中职位最高的是:TenPercentOwner(CEO、董事长和持股 10% 以上的股东得分最低)

Purchase-size comments are relative to the model scale. Average daily volume is a separate market-context diagnostic.

US-v1.2 按当前 180 天规则给合资格的股票买入打分。分数只表示研究的先后,不是收益预测或概率。回测没有显示美国分数越高、之后的表现越好。

内部人活动时间轴

申报人轨道展示最近 180 天。符号形状区分交易类型;卖出仅作为背景。

AprMayJunJulAugSepOct
HARARI ELIYAHOU ET ALTenPercentOwner
●●●●
Atkinson Douglas PatrickHead of Global Sales
○○
Shen Ching HangTenPercentOwner
●●
Imperial Joanne CarolDirector
▼○
Tsai Chen LungDirector
○
Kuo Hui YingDirector
○
● 买入▼ 卖出○ 其他

Showing the six most active owners; 3 additional owner(s) remain in Form 4 申报证据.

买方广度与集中度

合资格买方2
买入集中度52%最大买方: HARARI ELIYAHOU ET AL · $11.0M
聚集买入 · 15天2 insiders峰值活动: 2026-09-15–2026-09-18

Roles in the peak window: TenPercentOwner. Concentration uses priced qualifying P lines only and does not change the saved score.

信号历史

60.1 / 100

最新留档分数

↓ -0.3 pts相对上一个留档快照
  1. 60.7
  2. 60.6
  3. 60.5
  4. 60.4
  5. 60.1

Only scores saved when a full US scoring run completed are shown; gaps are not reconstructed.

近期 Form 4 活动

7买入
1卖出
17其他 Form 4 交易行
21SEC 申报 · 365天
买入7 qualifying P line(s) · 180 days
卖出1 sale line(s) · 仅供背景
其他10 exercise / withholding / award / gift / other lines
10b5-1/计划交易Not assessed

P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.

市场背景

市场背景补充近期价格表现与风险信息,不影响内部人信号。

价格表现

1M
+1.1%
3M
+5.9%
6M
+5.4%
12M
+43.3%

波动率与流动性

波动率
95.0%
Beta
—
平均每日成交额
USD 1.0M

估值

市值
USD 329.8M
P/E
—

基本面

利润率
-186.8%
ROE
-190.9%
细分行业
Medical Devices

市场数据

价格数据截至:2026-10-11 · 价格来源:OpenBB/yfinance; 成交量来自 本机价格缓存 (yfinance) · 来自 SEC 申报文件:市值, 利润率, ROE · 财年截止日:2025-12-31 · 市值 = 申报文件封面所列的已发行股数 × 最新收盘价。股数日期:2026-08-12 · Status: PASS

空头余额

空头余额是券商向 FINRA 申报的外部背景数据,不影响内部人信号。

空头股数
2,104,385
上期报告
1,899,065
日均成交量
386,803
回补天数
5.4

FINRA 结算日:2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数,每月两个结算日之后约一周公布;不是占已发行股份的比例。

历史股票买入

Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.

Transaction dateReporting owner类型证券股数平均价格估算金额来源
2026-09-18HARARI ELIYAHOU ET AL买入 (P)Common Stock1,757,469USD 5.69USD 9,999,999SEC 申报 ↗
2026-09-15Shen Ching Hang买入 (P)Common stock878,734USD 5.69USD 4,999,996SEC 申报 ↗
2026-09-15Shen Ching Hang买入 (P)Common stock878,734USD 5.69USD 4,999,996SEC 申报 ↗
2026-07-17HARARI ELIYAHOU ET AL买入 (P)Common Stock61,068USD 6.73USD 410,988SEC 申报 ↗
2026-07-08HARARI ELIYAHOU ET AL买入 (P)Common Stock81,300USD 6.09USD 495,117SEC 申报 ↗
2026-06-26HARARI ELIYAHOU ET AL买入 (P)Common Stock13,850USD 7.35USD 101,798SEC 申报 ↗
2025-07-03Tsai Chen Lung买入 (P)Common Stock20USD 4.17USD 83SEC 申报 ↗

Form 4 申报证据

25 transaction lines in the latest 365-day window; 35 in local history.

日期申报人类型证券股数平均价格估算金额来源
2026-09-18HARARI ELIYAHOU ET AL买入 (P)Common Stock1,757,469USD 5.69USD 9,999,999SEC 申报 ↗
2026-09-15Shen Ching Hang买入 (P)Common stock878,734USD 5.69USD 4,999,996SEC 申报 ↗
2026-09-15Shen Ching Hang买入 (P)Common stock878,734USD 5.69USD 4,999,996SEC 申报 ↗
展开近期 Form 4 证据 (22 grouped rows)
日期申报人类型证券股数平均价格估算金额来源
2026-09-18HARARI ELIYAHOU ET AL买入 (P)Common Stock1,757,469USD 5.69USD 9,999,999SEC 申报 ↗
2026-09-15Shen Ching Hang买入 (P)Common stock878,734USD 5.69USD 4,999,996SEC 申报 ↗
2026-09-15Shen Ching Hang买入 (P)Common stock878,734USD 5.69USD 4,999,996SEC 申报 ↗
2026-07-17HARARI ELIYAHOU ET AL买入 (P)Common Stock61,068USD 6.73USD 410,988SEC 申报 ↗
2026-07-08HARARI ELIYAHOU ET AL买入 (P)Common Stock81,300USD 6.09USD 495,117SEC 申报 ↗
2026-06-30Tsai Chen Lung期权行权/转换 (M)Common Stock2,022USD 7.58USD 15,327SEC 申报 ↗
2026-06-30Kuo Hui Ying期权行权/转换 (M)Common Stock2,022USD 7.58USD 15,327SEC 申报 ↗
2026-06-30King Wen-Herng Henry期权行权/转换 (M)Common Stock2,022USD 7.58USD 15,327SEC 申报 ↗
2026-06-30Imperial Joanne Carol期权行权/转换 (M)Common Stock2,022USD 7.58USD 15,327SEC 申报 ↗
2026-06-30Harari Michele期权行权/转换 (M)Common Stock2,022USD 7.58USD 15,327SEC 申报 ↗
2026-06-30GOUW JULIA S期权行权/转换 (M)Common Stock2,022USD 7.58USD 15,327SEC 申报 ↗
2026-06-26HARARI ELIYAHOU ET AL买入 (P)Common Stock13,850USD 7.35USD 101,798SEC 申报 ↗
2026-06-08Imperial Joanne Carol卖出 (S)Common Stock1,200USD 7.16USD 8,592SEC 申报 ↗
2026-05-05Atkinson Douglas Patrick期权行权/转换 (M)Common Stock34,786USD 0.57USD 19,828SEC 申报 ↗
2026-05-04Atkinson Douglas Patrick期权行权/转换 (M)Common Stock72,571USD 0.35USD 25,269SEC 申报 ↗
2026-04-17Shen Ching HangJ (J)Common stock3,991,606USD 0.00USD 0SEC 申报 ↗
2025-12-31Tsai Chen Lung期权行权/转换 (M)Common Stock2,887USD 10.69USD 30,862SEC 申报 ↗
2025-12-31Kuo Hui Ying期权行权/转换 (M)Common Stock2,887USD 10.69USD 30,862SEC 申报 ↗
2025-12-31King Wen-Herng Henry期权行权/转换 (M)Common Stock2,887USD 10.69USD 30,862SEC 申报 ↗
2025-12-31Imperial Joanne Carol期权行权/转换 (M)Common Stock2,887USD 10.69USD 30,862SEC 申报 ↗
2025-12-31Harari Michele期权行权/转换 (M)Common Stock2,887USD 10.69USD 30,862SEC 申报 ↗
2025-12-31GOUW JULIA S期权行权/转换 (M)Common Stock2,887USD 10.69USD 30,862SEC 申报 ↗

Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.

快照与身份

快照日期2026-10-18
排名版本US-v1.2
数据质量PASS ELIGIBLE · —
股票代码CV
CIK0001378325
行业Healthcare
细分行业Medical Devices Yahoo Finance
SEC SIC3845 Electromedical & Electrotherapeutic Apparatus
交易所Nasdaq

数据覆盖

本地 Form 4 历史35 transaction lines from 2025-07-03 to 2026-09-18
8 P purchase lines · 1 S sale lines · 26 other lines
SEC 公司申报打开 SEC 申报 ↗

Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.